1-2 of 2
Dominik Bartel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tafasitamab in Combination with a CD20xCD3 Bispecific T-Cell Engager Significantly Prolongs Survival in Preclinical Lymphoma Models

Eveline Schaadt, Christina Heitmüller, Solveig Peters, Kristina Ilieva, Derek Blair, Christiane Huth, Dominik Bartel, Sandra Zapf, Markus Eberl, Doris Mangelberger-Eberl, Frank Giles, Carsten Corvey
Journal: Blood
Blood (2023) 142 (Supplement 1): 2813.
https://doi.org/10.1182/blood-2023-188574
Published: 2023
Journal Articles

The Combination of Tafasitamab and Rituximab Increases Cytotoxicity Against Lymphoma Cells I n Vitro

Maria Patra, Christian Augsberger, Carmen Ginzel, Andrea Polzer, Karin Landgraf, Dominik Bartel, Daniel Ness, Stefan Steidl, Christina Heitmüller, Juergen Schanzer, Jan Endell
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-140381
Published: 2020